Sangamo Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
31.12.24
/
50%
€1.00
Target price
31.12.25
€2.90
Performance (%)
-61.99%
End price
03.01.26
€0.38
Summary
This prediction ended on 03.01.26 with a price of €0.38. Massive losses of -61.99% were the result for the BUY prediction by Jefferies_Financial_. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | -15.248% | -15.248% | -58.174% |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Jefferies Financial Group Inc. from $7.00 to $3.00. They now have a "buy" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten